Abortion access advocates said the ruling could have severe consequences on people's ability to access abortion and miscarriage care, especially after the overturning of Roe v. Wade. The federal government has seven days to appeal. More here:
A ruling by U.S. District Judge Matthew Kacsmaryk in Texas, a Trump appointee, put a halt on government approval of the drug, potentially decimating access to medication abortion nationwide. But just minutes later, a federal judge in Washington, Obama appointee U.S. District Judge Thomas O. Rice, ordered the Food and Drug Administration not to make any changes that would restrict access to the drug in 17 states and D.C. that sued to expand access to mifepristone.
Kacsmaryk's ruling in Texas means health care providers could be barred from prescribing mifepristone, even in states were abortion is legal. In-clinic, procedural abortion care will not be affected by the ruling. The decision"will unleash a public health crisis by removing health care options for millions of people," said Jenny Ma, senior counsel at the Center for Reproductive Rights.
"Simply put: this decision undermines the FDA’s ability to approve safe and effective medications—from chemotherapy drugs, to asthma medicine, to blood pressure pills, to insulin—based on science, not politics," Harris said in a statement.Even before the U.S. Supreme Court last year struck down the constitutional right to abortion granted by Roe v.
The ruling from the District Court for the Northern District of Texas"overturns the FDA’s expert judgment, rendered over two decades ago, that mifepristone is safe and effective. The Department will continue to defend the FDA’s decision," Garland said. In a statement, NARAL Pro-Choice America said the two competing rulings will almost certainly end up before the Supreme Court.Several legal experts said it was no accident the complaint was filed in Amarillo, Texas, where the only judge is Kacsmaryk, an appointee of former President Donald Trump who has a history of conservative rulings.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Access to Abortion Pill in Limbo After Competing Rulings in Texas, WashingtonA federal judge in Washington state on Friday ordered U.S. authorities not to make any changes that would restrict access to the abortion medication mifepristone in 17 Democratic-led states that sued over the issue, countering a ruling by a judge in Texas on the same day that ordered a hold on federal approval of the drug.
Baca lebih lajut »
Bus carrying farm workers from Texas to Washington crashes during snowstorm; 11 injuredA bus carrying contract farm workers from Texas to Washington state has crashed on a snowy road in southeastern Wyoming.
Baca lebih lajut »
Judge in Washington Orders Feds to Keep Abortion Pill Access, Countering Ruling in TexasA federal judge in Washington state on Friday ordered U.S. authorities not to make any changes that would restrict access to the abortion medication mifepristone in 17 Democratic-led states that sued over the issue, countering a ruling by a judge in Texas on the same day that ordered a hold on federal approval of the drug.
Baca lebih lajut »
Access to Abortion Pill in Limbo After Conflicting Rulings in Texas, WashingtonA federal judge in Washington state on Friday ordered U.S. authorities not to make any changes that would restrict access to the abortion medication mifepristone in 17 Democratic-led states that sued over the issue, countering a ruling by a judge in Texas on the same day that ordered a hold on federal approval of the drug.
Baca lebih lajut »
Access to abortion pill mifepristone uncertain after rulings in Texas, WashingtonFor now, the drug that the Food and Drug Administration approved in 2000 remains at least immediately available in wake of the separate rulings that were...
Baca lebih lajut »
Houston-Xavier one of matchups set for Big East-Big 12 battleDefending national champion UConn, Texas, Baylor, TCU and Texas Tech, among others, will...
Baca lebih lajut »